Antineoplastics/programmed-cell-death-1-receptor-antagonistsNeuropathy and lack of efficacy: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1936卷 / 1期

关键词：

D O I：

10.1007/s40278-022-29278-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：81 / 81

相关论文

共 50 条

[1] Antineoplastics/programmed-cell-death-1-receptor-antagonistsLack of efficacy: 8 case reports
Reactions Weekly, 2023, 1950 (1) : 59 - 59
[2] Antineoplastics/diazoxideOedema and lack of efficacy: 4 case reports
Reactions Weekly, 2023, 1940 (1) : 73 - 73
[3] Antineoplastics/steroidsRash and lack of efficacy: 6 case reports
Reactions Weekly, 2022, 1935 (1) : 85 - 85
[4] Cytokine-induced-killer-cell-therapy and programmed-cell-death-1-receptor-antagonistsVarious toxicities and Lack of efficacy: 2 case reports
Reactions Weekly, 2021, 1877 (1) : 126 - 126
[5] Lenvatinib/unspecified programmed-cell-death-1-receptor-antagonistsLack of efficacy: 2 case reports
Reactions Weekly, 2025, 2042 (1) : 252 - 252
[6] Programmed-cell-death-1-receptor-antagonists/rivoceranibVarious toxicities: 3 case reports
Reactions Weekly, 2020, 1833 (1) : 331 - 331
[7] Antineoplastics/antibiotics/vasopressorsStenotrophomonas maltophilia infection and lack of efficacy: 3 case reports
Reactions Weekly, 2025, 2050 (1) : 66 - 66
[8] Antineoplastics/antithymocyte-globulinGraves' disease and lack of efficacy: 3 case reports
Reactions Weekly, 2023, 1968 (1) : 45 - 45
[9] Antineoplastics/mTOR-protein-inhibitorsDiarrhoea and lack of efficacy: 3 case reports
Reactions Weekly, 2021, 1870 (1) : 45 - 45
[10] Antineoplastics/filgrastim/pegfilgrastimAortitis and lack of efficacy: 9 case reports
Reactions Weekly, 2020, 1830 (1) : 55 - 55

← 1 2 3 4 5 →